Authors: Vereschagin, NV Suslina, ZA Timerbaeva, SL Kashina, EM Gnezditsky, VV Maksimova, MY Rebrova, OY Smirnova, IA

Citation: Nv. Vereschagin et al., Treatment and prevention of cognitive dysfunction in patients with arterial hypertension and atherosclerosis: Results of randomised double blind placebo-controlled study of cerebrolysin, TERAPEVT AR, 73(4), 2001, pp. 22-27

Authors: Geraskina, LA Suslina, ZA Fonyakin, AV

Citation: La. Geraskina et al., Cerebral vasomotor reactivity in patients with discirculatory hypertensiveencephalopathy and cerebral hypoperfusion risk, TERAPEVT AR, 73(2), 2001, pp. 43-48

Authors: Timerbaeva, SL Suslina, ZA Bodareva, EA Fedin, PA Korepina, OS Pervozvansky, BE

Citation: Sl. Timerbaeva et al., Tanakan in the treatment of primary manifestations of insufficiency of brain blood supply, ZH NEVR PS, 100(8), 2000, pp. 24-28

Authors: Suslina, ZA Fedorova, TN Maksimova, MY Ryasina, TV Stvolinsky, SL Khrapova, EV Boldyrev, AA

Citation: Za. Suslina et al., Antioxidant therapy in ischemic stroke, ZH NEVR PS, 100(10), 2000, pp. 34-38

Authors: Suslina, ZA Fedorova, TN Kistenev, BA Khrapova, EV Maksimova, MY

Citation: Za. Suslina et al., Dynamics of lipid peroxidation in patients with acute ischemic stroke, ZH NEVR PS, 99(7), 1999, pp. 33-36